Inactive Instrument

Calendar Arsanis Inc Nasdaq

Equities

US0428731097

Chart calendar Arsanis Inc

4921d6a661510.zJ9xTKOmn6X82L-KKxHEDvicab8UwGW6b3QhGiVmHGM.uMUdHOTy9NeYsN7pXUSyXJH4EPx9-CbjFR1QYGlUZjGl7SIK0_HWyoauyA~2c283c8692b412bbb63959ec47dc204c

Upcoming events on Arsanis Inc

2024-05-08 Q1 2024 Earnings Release (Projected)
2024-07-31 Q2 2024 Earnings Release (Projected)
2024-11-06 Q3 2024 Earnings Release (Projected)
2025-03-12 Q4 2024 Earnings Release (Projected)

Past events on Arsanis Inc

2024-04-16 Piper Sandler Spring Biopharma Symposium
2024-04-08 09:30 am Needham Healthcare Conference
2024-03-21 08:30 am Q4 2023 Earnings Call
2024-03-21 06:01 am Q4 2023 Earnings Release
2023-11-28 01:00 pm Piper Sandler Healthcare Conference
2023-11-14 04:10 pm Stifel Healthcare Conference
2023-11-09 08:30 am Q3 2023 Earnings Call
2023-11-09 06:01 am Q3 2023 Earnings Release
2023-09-26 04:55 pm Cantor Global Healthcare Conference
2023-09-13 07:30 am Morgan Stanley Global Healthcare Conference
2023-08-10 08:30 am Q2 2023 Earnings Call
2023-08-10 06:05 am Q2 2023 Earnings Release
2023-05-21 12:30 pm Clinical Immunology Society Meeting
2023-05-16 04:00 pm 4WHIM Phase 3 Clinical Data Results Call
2023-05-04 08:30 am Q1 2023 Earnings Call
2023-05-04 06:05 am Q1 2023 Earnings Release
2023-03-21 09:00 am Q4 2022 Earnings Call
2023-03-21 06:05 am Q4 2022 Earnings Release
2022-11-29 04:30 pm 4WHIM Phase 3 Trial Results Call
2022-11-15 03:00 pm Stifel Healthcare Conference

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
0,00
0,00
-
3,00
2,25
33.33%
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

28,7

EBITDA
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00

EBIT
Million USD
Released
Forecast
Spread
-51,7
-51,7
-0.01%
-59,9
-60,1
0.43%
-75,3
-76,0
0.8%
-87,6
-84,6
-3.46%
-108
-111
3.36%

-106

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-52,8
-55,2
4.41%
-62,0
-61,9
-0.08%
-88,7
-79,1
-12.16%
-93,8
-88,3
-6.31%
-101
-112
9.52%

-94,3

Net income
Million USD
Released
Forecast
Spread
-53,4
-55,2
3.34%
-62,1
-62,0
-0.19%
-103
-79,5
-29.05%
-96,4
-89,3
-8.01%
-101
-112
9.5%

-94,3

EPS
USD
Released
Forecast
Spread
-4,63
-4,47
-3.62%
-3,09
-3,08
-0.45%
-3,99
-3,08
-29.55%
-1,52
-1,43
-6.29%
-0,57
-0,63
10.14%

-0,45

Announcement Date12/03/2004/03/2117/03/2221/03/2321/03/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Million USD
Released
Forecast
Spread
0,00
0,00
-
0,00
0,11
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00


15,5


3,18


10,0


12,3

EBIT
Million USD
Released
Forecast
Spread
-19,3
-19,9
2.99%
-21,3
-20,1
-5.97%
-20,6
-21,8
5.47%
-20,2
-20,9
3.36%
-25,6
-22,4
-14.22%
-29,3
-24,6
-18.98%
-25,8
-26,2
1.57%
-27,2
-26,3
-3.61%
-25,2
-28,9
12.94%

-29,3


-16,4


-32,2


-27,8


-35,2

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-30,2
-20,6
-46.71%
-21,9
-20,7
-6.01%
-21,2
-22,4
5.36%
-21,6
-21,4
-0.94%
-29,1
-23,2
-25.65%
-24,0
-25,3
5.13%
-55,7
-26,6
-109.07%
-2,28
-26,7
91.47%
-19,1
-29,7
35.78%

-29,7


-2,67


-33,1


-28,8


-35,5

Net income
Million USD
Released
Forecast
Spread
-35,9
-19,9
-80.57%
-24,2
-20,7
-17.04%
-21,2
-22,4
5.34%
-21,9
-21,4
-2.22%
-29,1
-23,2
-25.71%
-24,0
-25,7
6.53%
-55,7
-26,6
-109.13%
-2,31
-26,7
91.37%
-19,1
-29,7
35.67%

-29,7


-2,67


-33,1


-28,8


-35,5

EPS
USD
Released
Forecast
Spread
-1,24
-0,68
-81.59%
-0,72
-0,61
-18.31%
-0,60
-0,64
6.49%
-0,26
-0,30
13.33%
-0,29
-0,24
-20.21%
-0,16
-0,22
26.31%
-0,33
-0,17
-95.39%
-0,01
-0,15
93.28%
-0,10
-0,15
34.58%

-0,15


-0,03


-0,16


-0,14


-0,18

Announcement Date17/03/2212/05/2204/08/2203/11/2221/03/2304/05/2310/08/2309/11/2321/03/24-----